\
&
Contact us
\
&
Contact us
This was 8 months ago
LocationBrussels
ProgrammesIn today’s digital age, online identity theft and the proliferation of fake information pose pressing challenges to individuals, organisations, and governments worldwide. As technology continually evolves, so do the tactics employed by malicious actors, leading to increasingly sophisticated methods of stealing personal information and disseminating false narratives.
This workshop will explore these critical issues, exploring current trends, emerging threats, and potential solutions within the context of the EU’s security research and innovation efforts.
Event organiser: CERIS - Community for European Research and Innovation for Security
For more information on this event and to register, please visit the dedicated event page via this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
